AIM AIM ImmunoTech Inc.: Net earnings per share for the last 12 months
AIM ImmunoTech is exposed to geopolitical risks due to its reliance on foreign patents and the complexities of importing components. The annual net income per share trend visualizes these challenges, with the latest value recorded as -3.84. The development of RNA drugs is constrained by strict regulatory oversight and labor-intensive biochemical synthesis. Since the company is in the pre-revenue stage, its existence relies on equity issuance rather than sales.
%20Net%20earnings%20per%20share%20(EPS%20TTM)&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_AIM_-_AIM-ImmunoTech_-_Net-earnings-per-share-EPS-TTM "AIM AIM ImmunoTech, Inc.: Earnings per share for the last twelve months in the range 07/04/2022 - 11/11/2026 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for aimimmuno.com (AIM)
- current quotes and average value forecast:
- company stock capitalization data:
- balance sheet net asset value indicators:
- debt level and financial liquidity data:
Total Debt to Capital AIM ImmunoTech|AIM - Long-Term Debt to Capital|Short-Term Debt to Capital AIM ImmunoTech Inc.|AIM - Company Total Debt Obligations|Debt to Book Capitalization Ratio AIM ImmunoTech Inc.|AIM - Company Long-Term Liabilities|Company Current Liabilities AIM ImmunoTech|Quick Ratio aimimmuno.com
- earnings and multiples data:
AIM - Net Financial Result|Expected Profit AIM ImmunoTech|AIM - Price to Earnings Ratio|Future Price to Earnings AIM ImmunoTech|AIM - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio AIM ImmunoTech Inc.|AIM - Operating profit EBITDA|Earnings per share for the last twelve months AIM ImmunoTech|AIM - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months aimimmuno.com|AIM - Earnings per share growth rate in current year|Expected earnings per share growth for next year AIM ImmunoTech
Fundamental company analysis:AIM - AIM ImmunoTech
This indicator reflects the actual efficiency of profit generation per share. By analyzing the current trailing 12-month EPS, an investor assesses the fundamental stability of capital. The metric is calculated by dividing the company's total annual net income by the total number of shares. For AIM ImmunoTech (AIM), this figure confirms the financial base supporting an elite staff of immunologists and the development of the R&D platform.
Competitor analysis
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|ABVX (Abivax Pharma) - Net earnings per share for the last 12 months|ADMA Biologics Inc (ADMA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Protagonist Therapeutics Inc|Earnings per share for the last 12 months IMVT (Immunovant Therapeutics)|Net earnings per share (EPS TTM) KNSA|GRFS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Net earnings per share (EPS TTM) Celldex Therapeutics Inc CLDX|Aurinia Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioCryst Corp BCRX|Vera Therapeutics, Inc. (VERA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months dianthustx.com|Net earnings per share for the last 12 months PHVS|ABCL: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TRML|Net earnings per share for the last four quarters Precigen Corp|Earnings per share for the last twelve months Pharming Group N.V. PHAR|NKTR - Net earnings per share for the last 12 months|UPB - Earnings per share for the last twelve months|Zenas Bio (ZBIO) - Net earnings per share for the last 12 months|IMNM (Immunome Corp) - Net earnings per share for the last 12 months|Gossamer Bio Corp. (GOSS) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KalVista Pharmaceuticals|Earnings per share for the last 12 months SEPN (septerna.com)|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|SVRA - Net earnings per one share for the last twelve months|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANAB (AnaptysBio Inc.)|Astria Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months engene.com|RAPT: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aerovate Therapeutics|ACRS (Aclaris) - Net earnings per share (EPS TTM)|KYTX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TLSA|Net earnings per share (EPS TTM) cabalettabio.com (CABA)|Net earnings per share (EPS TTM) VTYX (Ventyx Biosciences, Inc.)|Net earnings per share for the last four quarters Theratechnologies, Inc. (THTX)|AVTX - Earnings per share for the last twelve months|Eledon Pharmaceuticals, Inc (ELDN) - Net earnings per share for the last 12 months|Agenus (AGEN) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months CLYM (climbbio.com)|ZURA (Zura Bio Limited) - Net earnings per share (EPS TTM)|ATYR: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) ikenaoncology.com (IMA)|Earnings per share for the last twelve months Shattuck Labs STTK|Earnings per share for the trailing year EQ|CNTB - Earnings per share for the last twelve months|Immunic, Inc. (IMUX) - Net earnings per share for the last 12 months|ATRA: Net earnings per share (EPS TTM)|InflaRx (IFRX) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months XFOR|ACET: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CELU|Net earnings per share for the last four quarters INmune Bio Inc|Earnings per share for the last twelve months Barinthus Bio BRNS|KZR - Net earnings per share for the last 12 months|SABS - Earnings per share for the last twelve months|akaritx.com (AKTX) - Net earnings per share for the last 12 months|ENLV (enlivex.com) - Net earnings per share for the last 12 months|Q32 Bio (QTTB) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months GeoVax Labs Inc|Earnings per share for the last 12 months EDSA (Edesa Biotech Corp)|Net earnings per share (EPS TTM) IBIO|CARM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) XTLB (XTL Biopharmaceuticals Ltd.)|Net earnings per share (EPS TTM) Bolt Biotherapeutics Inc. BOLT|HCW Biologics Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Aptevo Therapeutics APVO|aditxt.com (ADTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months gribio.com|Net earnings per share for the last 12 months XRTX|HIND: Earnings per share for the trailing year|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last four quarters Indaptus Corp|Earnings per share for the last twelve months Scinai Immunotherapeutics SCNI|CALI - Net earnings per share for the last 12 months|AFMD - Earnings per share for the last twelve months|Allakos Inc. (ALLK) - Net earnings per share for the last 12 months|HOOK (hookipapharma.com) - Net earnings per share for the last 12 months|IGM Biosciences (IGMS) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months iTeos Therapeutics|Earnings per share for the last 12 months OCEA (oceanbiomedical.com)|Earnings per share for the last twelve months TC BioPharm (TCBP)|THRD - Net earnings per one share for the last twelve months
